Start for free
Start for free
HC

Hermed Capital

Asia, Shanghai, China, Shanghai

Description

Hermed Capital is a Hong Kong-based financial services company that offers related advisory services.

Investor Profile

Hermed Capital has made 5 investments, with 0 in the past 12 months and 60% as lead.

Stage Focus

  • Series D (40%)
  • Series A (20%)
  • Series C (20%)
  • Series B (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Health Care
  • Medical
  • Hospital
  • Precision Medicine
  • Biopharma
  • Life Science
  • Oncology
  • Analytics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hermed Capital frequently co-invest with?

Genomic Health
Genomic Health
North America, California, United States, Redwood City
Co-Investments: 1
Sabby Capital
Sabby Capital
North America, New Jersey, United States, Upper Saddle River
Co-Investments: 1
Domain Associates
Domain Associates
North America, California, United States, San Diego
Co-Investments: 1
RT
Co-Investments: 1
RMI Partners
RMI Partners
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
AC
Altos Capital Partners
North America, California, United States, Los Altos
Co-Investments: 1
3B Future Health Fund
3B Future Health Fund
Europe, Bayern, Germany, Monaco
Co-Investments: 1
Pagoda Investment
Pagoda Investment
Asia, Beijing, China, Beijing
Co-Investments: 1
V
Viventures
North America, California, United States, San Mateo
Co-Investments: 2
Ping An Ventures
Ping An Ventures
Asia, Shandong, China, Pudong
Co-Investments: 2

Which angels does Hermed Capital often collaborate with?

LL
Leo Liu
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Hermed Capital?

Prognos Health

New York, New York, United States

Prognos Health creates a healthcare analytics platform that uses patient-level data to generate clinical insights.

AnalyticsHealth CareHealth Diagnostics
Series CNov 27, 2017
Amount Raised: $20,500,000
Aadi Bioscience

Pacific Palisades, California, United States

Aadi Bioscience develops a potentially mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases.

BiopharmaBiotechnologyLife ScienceOncology
Series AMay 8, 2017
Amount Raised: $23,000,000
Epic Sciences

La Jolla, California, United States

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

BiotechnologyHealth CareHealth DiagnosticsHospitalPrecision Medicine
Series DApr 28, 2017
Amount Raised: $40,000,000
Applied StemCell

Milpitas, California, United States

Applied StemCell is a biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics.

BiotechnologyGeneticsHealth DiagnosticsMedical
Series DJun 6, 2016
Amount Raised: $19,000,000
Ativa Medical

Saint Paul, Minnesota, United States

Ativa Medical is working to make diagnostic test results available in moments, rather than hours and days.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series BSep 17, 2015
Amount Raised: $15,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator